Instrument Inactif

Autres langues ALPA HEAL

Actions

ALPA

US02073F1049

Autres langues

20/03/24	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
18/03/24	Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
26/02/24	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
16/11/23	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
16/11/23	ALPA HEAL : Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - Form 8-K
15/11/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
06/09/23	Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics
14/08/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
21/07/23	ALPA HEAL : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K
17/07/23	Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation
17/07/23	Alpha Healthcare Acquisition Corp. III(NasdaqCM:ALPA) dropped from NASDAQ Composite Index
14/07/23	Alpha Healthcare Acquisition Completes Combination With Carmell Therapeutics
14/07/23	Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation
14/07/23	Carmell Therapeutics Corporation completed the acquisition of Alpha Healthcare Acquisition Corp. III from a group of shareholders in a reverse merger transaction.
10/07/23	Alpha Healthcare Acquisition III : Material Agreement - Form 8-K
06/07/23	Carmell Therapeutics Merger With Alpha Healthcare Acquisition Corp III (Nasdaq: ALPA) July 6, 2023 - Form 8-K
27/06/23	Alpha Healthcare Acquisition Executes Non-Binding Letter of Intent to Acquire Regenerative Medicine Company
27/06/23	Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination
15/05/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2023
02/05/23	ALPHA HEALTHCARE ACQUISITION CORP III : Other Events (form 8-K)
31/03/23	ALPHA HEALTHCARE ACQUISITION CORP III : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
17/03/23	ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
17/03/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022
17/03/23	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022
17/03/23	Alpha Healthcare Acquisition Corp. III Auditor Raises 'Going Concern' Doubt